AstraZeneca, CSPC ink AI drug development deal for $110M upfront 

AstraZeneca is further tightening its relationship with China, announcing a new research partnership with CSPC Pharmaceuticals on Friday. CSPC will receive $110 million upfront for the partners to develop preclinical oral candidates for different chronic …